Drug Shortage Report for VIOKACE

Last updated on 2022-10-07 History
Report ID 153899
Drug Identification Number 02241933
Brand name VIOKACE
Common or Proper name Pancrelipase
Company Name NESTLE ENTERPRISES S.A.
Market Status MARKETED
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 113400UNIT 112500UNIT 20880UNIT
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 tablet bottles
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2022-08-01
Actual start date 2022-09-01
Estimated end date
Actual end date 2022-10-06
Shortage status Resolved
Updated date 2022-10-07
Company comments We are pleased to tell you that Viokace 10440 and Viokace 20880 stock is now available for sale. Please place your orders as you normally would (either through EDI order by contacting Customer Service at): orders@apcipharma.com. Thank you for your patience.
Health Canada comments
Tier 3 Status No
Contact Address 12, RUE ENTRE-DEUX-VILLES
VEVEY, --
SWITZERLAND 1800
Company contact information kfeltmate@apcipharma.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2022-10-07 English Compare
v14 2022-10-06 French Compare
v13 2022-10-06 English Compare
v12 2022-09-02 English Compare
v11 2022-09-01 French Compare
v10 2022-09-01 English Compare
v9 2022-09-01 English Compare
v8 2022-08-02 English Compare
v7 2022-07-08 French Compare
v6 2022-07-08 English Compare
v5 2022-01-31 French Compare
v4 2022-01-31 English Compare
v3 2022-01-31 French Compare
v2 2022-01-31 French Compare
v1 2022-01-31 English Compare

Showing 1 to 15 of 15